Unleashing the potential of ferroptosis, autophagy, and mitochondrial dynamics as emerging modalities in cancer treatment

doi:10.5306/wjco.v16.i7.107788

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 16, Issue 7

This Article

Academic Content and Language Evaluation of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

Total Article Views (179)

All Articles published online

The chart showing PDF series, HTML series, Figures (1-4) series.

Item

Count

PDF

HTML

123

Figures (1-4)

Sum=160

Publishing Process of This Article

The chart showing Browse series, Download series.

Item

Count

Browse

Download

Sum=10

Jul 24, 2025 (publication date) through Jul 25, 2025

Times Cited of This Article

Times Cited (0)

Journal Information of This Article

Publication Name

World Journal of Clinical Oncology

ISSN

2218-4333

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Minireviews

World J Clin Oncol. Jul 24, 2025; 16(7): 107788
Published online Jul 24, 2025. doi: 10.5306/wjco.v16.i7.107788

Unleashing the potential of ferroptosis, autophagy, and mitochondrial dynamics as emerging modalities in cancer treatment

Tanha Ashok Rana, Akhilesh Prajapati

Tanha Ashok Rana, Akhilesh Prajapati, Department of Life Sciences, Biotechnology Division, School of Science, GSFC University, Vadodara 391750, Gujarat, India

Author contributions: Rana TA and Prajapati A collaboratively designed, discussed, and wrote the review manuscript; Prajapati A conceptualized the idea, provided critical insights, and supervised the overall preparation of the review.

Supported by GSBTM, DST, Government of Gujarat for their Financial Support on the Breast Cancer Stem Cell Research Project at GSFC University, Vadodara, No. GSBTM/JD/(R&D) 610/20-21/346.

Conflict-of-interest statement: The authors have no conflicts of interest to declare.

Open Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/

Corresponding author: Akhilesh Prajapati, PhD, Senior Assistant Professor, Department of Life Sciences, Biotechnology Division, School of Science, GSFC University, Vadodara 391750, Gujarat, India. akhileshbiotech06@gmail.com

Received: April 1, 2025
Revised: April 22, 2025
Accepted: June 3, 2025
Published online: July 24, 2025
Processing time: 115 Days and 21.2 Hours

Core Tip

Core Tip: This review explores the emerging therapeutic potential of ferroptosis, autophagy, and mitochondrial dynamics in cancer treatment. By targeting ferroptosis—an iron-dependent form of cell death—alongside the modulation of autophagy and mitochondrial function, novel strategies can be developed to overcome cancer cell resistance and metastasis. Understanding the intricate interplay among these processes offers a promising avenue for more effective and personalized cancer therapies.